These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23328468)

  • 1. [Primary exploration of individual biological boosting target volume for locally advanced nasopharyngeal carcinoma].
    Wen G; Huang XB; Zhang WD; Lin XP; He ZC; Xia YF
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(45):3207-10. PubMed ID: 23328468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dosimetric analysis of radiotherapy with middle shielding blocks of different widths at the lower cervical supraclavicular field for stage N2-3 nasopharyngeal carcinoma].
    Li FM; Luo W; He ZC; Zhang L; Sun Y; Qin WJ; Lu LX; Han F; Liu XQ; Liu MZ
    Ai Zheng; 2007 Oct; 26(10):1127-32. PubMed ID: 17927886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
    Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
    Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
    Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volume and dosimetric variations during two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma.
    Wang RH; Zhang SX; Zhou LH; Zhang GQ; Yu H; Lin XD; Lin S
    Biomed Mater Eng; 2014; 24(1):1217-25. PubMed ID: 24212016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.
    Gai X; Wei Y; Tao H; Zhu J; Li B
    Oncotarget; 2017 Apr; 8(16):27529-27540. PubMed ID: 28404877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of (99)Tc(m)-MDP SPECT/CT in clinical decision-making for nasopharyngeal carcinoma and a comparison of the values of different imaging techniques for diagnosing skull-base bone invasion].
    Li W; Zhang RS; Zhang LQ; Lu BG; Fu WH
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):133-137. PubMed ID: 28219209
    [No Abstract]   [Full Text] [Related]  

  • 8. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
    Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Irradiation field design according to locoregional relapse sites after radiotherapy of nasopharyngeal carcinoma].
    Luo W; Tang YQ; Huang Y; Lu LX; Lu TX
    Ai Zheng; 2006 Feb; 25(2):209-11. PubMed ID: 16480588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will weight loss cause significant dosimetric changes of target volumes and organs at risk in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy?
    Chen C; Fei Z; Chen L; Bai P; Lin X; Pan J
    Med Dosim; 2014; 39(1):34-7. PubMed ID: 24140235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of SPECT/CT, MRI and CT in diagnosis of skull base bone invasion in nasopharyngeal carcinoma.
    Zhang SX; Han PH; Zhang GQ; Wang RH; Ge YB; Ren ZG; Li JS; Fu WH
    Biomed Mater Eng; 2014; 24(1):1117-24. PubMed ID: 24212004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new brain positron emission tomography scanner with semiconductor detectors for target volume delineation and radiotherapy treatment planning in patients with nasopharyngeal carcinoma.
    Katoh N; Yasuda K; Shiga T; Hasegawa M; Onimaru R; Shimizu S; Bengua G; Ishikawa M; Tamaki N; Shirato H
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e671-6. PubMed ID: 22245187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
    Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
    Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Error in the parotid contour delineated using computed tomography images rather than magnetic resonance images during radiotherapy planning for nasopharyngeal carcinoma.
    Liu C; Kong X; Gong G; Liu T; Li B; Yin Y
    Jpn J Radiol; 2014 Apr; 32(4):211-6. PubMed ID: 24558018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and toxicity of individualized intensity-modulated radiotherapy based on the tumor extension patterns of nasopharyngeal carcinoma.
    Lin L; Yao JJ; Zhou GQ; Guo R; Zhang F; Zhang Y; Xu L; Zhang LL; Lin AH; Ma J; Sun Y
    Oncotarget; 2016 Apr; 7(15):20680-90. PubMed ID: 26980744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of radiation dose by the skull base bone in patients with nasopharyngeal carcinoma: clinical importance.
    Hsiung CY; Wu JM; Wang CJ; Kuo SC; Yeh SA; Hsu HC; Huang EY
    Radiology; 2001 Feb; 218(2):457-63. PubMed ID: 11161162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and long-term efficacy of four facio-cervical fields conformal radiotherapy for nasopharyngeal carcinoma.
    Fangzheng W; Chuner J; Lei W; Weijun C; Min X; Quanquan S; Tongxin L; Aizawa R; Sakamoto M; Zhenfu F
    Oncotarget; 2017 Jun; 8(24):39756-39765. PubMed ID: 28055973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.
    Chan OS; Sze HC; Lee MC; Chan LL; Chang AT; Lee SW; Hung WM; Lee AW; Ng WT
    Head Neck; 2017 Mar; 39(3):533-540. PubMed ID: 27898191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Pilot Trial Comparing Position Emission Tomography (PET)-Guided Dose Escalation Radiotherapy to Conventional Radiotherapy in Chemoradiotherapy Treatment of Locally Advanced Nasopharyngeal Carcinoma.
    Wang J; Zheng J; Tang T; Zhu F; Yao Y; Xu J; Wang AZ; Zhang L
    PLoS One; 2015; 10(4):e0124018. PubMed ID: 25915944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.